Vabysmo 6 MG/0.05 ML syringe 0.05ML
Ended Awarded Last action
- Contract number
- SPE2DR26FRRH7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,134
Award facts
- Contract value 100% obligated
- $9,134.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $9,134.34 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Vabysmo 6 mg/0.05 ml syringes. This firm fixed-price delivery order was issued on December 16, 2025, with an ultimate completion date of January 8, 2026, and carries no set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. The product will be delivered to Park Ridge, Illinois, supporting the Department of Defense's pharmaceutical supply requirements.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to supply branded and generic pharmaceuticals, biologics, and medical consumables to military healthcare facilities worldwide. The parent IDC, designated SPE2DR and awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a critical regional pharmaceutical supplier for Department of Defense healthcare operations globally. The vendor has demonstrated substantial performance on numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division, handling products across multiple therapeutic categories including specialty pharmaceuticals and biologics.
Quick answers
Who was awarded contract SPE2DR26FRRH7?
SPE2DR26FRRH7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FRRH7 worth?
The government has obligated $9,134 on SPE2DR26FRRH7.
Is contract SPE2DR26FRRH7 an order under another contract?
Yes. SPE2DR26FRRH7 is a delivery order under SPE2DR25D9238, an indefinite delivery contract.
Was contract SPE2DR26FRRH7 competed?
The extent of competition for SPE2DR26FRRH7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award